Related by context. All words. (Click for frequent words.) 73 K#N 69 NRTI resistance 69 K#R [002] 66 methylenetetrahydrofolate reductase 65 Pharmacokinetics PK 65 K ras mutations 65 IL#B 65 indinavir 65 NNRTI resistant virus 65 IgG1 64 PEG IFN 64 HCV replicon 64 KIF6 gene 64 dinucleotide 64 PD# [005] 64 V#F 64 C#T [002] 64 rs# [004] 64 CD# CD# 64 Klebsiella pneumonia 64 abacavir lamivudine 64 AZT zidovudine Retrovir 64 CC genotype 64 3TC lamivudine Epivir 64 IgG antibody 64 sunitinib Sutent ® 63 beta3 63 pDC 63 promoter methylation 63 C#Y 63 Enterobacter cloacae 63 T#I [002] 63 lamivudine resistant 63 clade B 63 CYP#A# CYP#D# 63 ABCB1 63 heterozygotes 63 reverse transcriptase inhibitors 63 ertapenem 63 MTHFR 63 specific CD8 + 63 pharmacologically active isomer 63 S#T [001] 63 LNCaP 63 #S rRNA genes 63 homozygotes 63 c KIT 62 hemagglutination inhibition 62 methicillin susceptible Staphylococcus aureus 62 tumor xenograft models 62 multivariate Cox 62 ceftazidime 62 UGT#A# * 62 ritonavir boosted 62 BALB c mice 62 CYP #C# 62 DR4 62 monocytic 62 splice variants 62 CYP#C# [002] 62 5alpha reductase 62 bivalent 62 Mg Uk 62 syngeneic 62 atovaquone 62 selective modulator 62 NSCLC tumors 62 RRM1 62 enteroviral 62 nonnucleoside reverse transcriptase inhibitors 62 VKORC1 62 oxacillin 62 GSTP1 62 EGFR HER2 62 abacavir Ziagen 62 C#T [001] 62 variant allele 62 MDR1 62 Antitumor 62 L. pneumophila 62 Albuferon TM 62 FDG PET imaging 62 NNRTI resistance 62 Conjugate 62 apolipoprotein B 62 Gigabyte GV 62 FLT3 62 E7 proteins 61 murine leukemia 61 erlotinib Tarceva ® 61 flavopiridol 61 papillary renal cell carcinoma 61 potent inhibition 61 tigecycline 61 ESR1 61 HER2/neu 61 HCV genotypes 61 AZT 3TC 61 Estrogen Receptor 61 Pegylated 61 Streptococcus agalactiae 61 R5 tropic 61 Upregulation 61 DU# [002] 61 Pegylated Liposomal Doxorubicin 61 squamous intraepithelial lesions 61 ethambutol 61 prostate carcinoma 61 hepatocellular carcinomas 61 invasive carcinomas 61 M#V mutation 61 microsatellite instability 61 genotypic resistance 61 Apolipoprotein 61 HBeAg negative 61 VEGFR1 61 dexamethasone Decadron 61 p# antigen 61 flutamide 61 liposomal doxorubicin 61 antibody titer 61 KRAS mutations 61 cyclin dependent kinase inhibitor 61 Neisseria gonorrhoeae 61 hepatoma 61 murine leukemia virus 61 T#M 61 Gleevec resistant 61 immunohistochemical analysis 61 F#del 61 tenofovir TDF 61 BRSV 61 Lenalidomide 61 CIN2 + 61 pancreatic ductal adenocarcinoma 61 PEGylated Fab fragment 61 H. influenzae 61 colon carcinoma 61 ergot derivatives 61 Mutation Detection 61 KRAS oncogene 61 CDKN2A 61 Deadlinepix 61 Adenoviral 61 tissue transglutaminase 61 Sanofi Pasteur Fluzone 61 replicon 61 Omacetaxine mepesuccinate 61 Antigen Specific 61 metastatic malignant 61 acid phosphatase PAP 61 p# biomarker 61 thyroid peroxidase 61 hypereosinophilic syndrome 61 pT2 61 Dendritic Cell 61 P#P#D 60 Respiratory Virus 60 receptor tyrosine kinase inhibitor 60 includes S. anginosus 60 xenograft model 60 Gilead Viread 60 Somatostatin 60 monovalent 60 Orally Active 60 Vitro Activity 60 ELISPOT 60 solithromycin 60 Histologic 60 Alanine 60 Ultrasensitive 60 MAGE A3 ASCI 60 adriamycin 60 isoenzyme 60 caspofungin 60 μg ml 60 Leydig cell 60 paramyxoviruses 60 CDK4 60 SERMs 60 Trichomonas vaginalis 60 MTHFR gene 60 pertussis toxin 60 N. gonorrhoeae 60 biologic DMARD 60 III EGFRvIII 60 amprenavir 60 mutated K ras 60 ODNs 60 virologic failures 60 imatinib Gleevec ® 60 conserved antigens NP 60 Protease Inhibitors 60 inhibitor RG# 60 HLA DR4 60 orally administered inhibitor 60 GHRH 60 trivalent influenza vaccine 60 protein tyrosine phosphatase 1B 60 daunorubicin 60 gemcitabine carboplatin 60 HepG2 cells 60 non nucleoside inhibitor 60 refractory anemia RA 60 PAM4 60 HBsAg 60 rs# [001] 60 receptor blocker 60 probiotic Lactobacillus 60 Squamous 60 pyrazinamide 60 #ß 60 LAB CGRP 60 Quantitation 60 Chlamydia trachomatis 60 antiretroviral naïve 60 HLA A2 60 KRAS mutation 60 tenofovir Viread 60 inactivated influenza 60 CCR5 delta# 60 immunostimulatory 60 DG# [003] 60 Haptoglobin 60 Staphylococcus epidermidis 60 NS5B polymerase 60 Epidermal Growth Factor Receptor 60 Subtype 60 complete cytogenetic response 60 neutralizing antibody responses 60 orthopoxvirus 60 pentamidine 60 Leukemias 60 Polymerase Inhibitor 60 S. constellatus 60 monocyte chemotactic protein 60 oseltamivir resistant 60 prostanoid 60 rifabutin 60 S. intermedius 60 Motherboard Benchmark Reviews 60 cefotaxime 60 rifamycins 60 hyaluronidase enzyme 60 activating mutation 60 Highly Pathogenic 60 CYP#C# gene 60 D#N 60 transgene expression 60 Bifidobacterium lactis 60 lupus anticoagulant 60 Fludara ® 60 fosbretabulin 60 thymidine kinase 60 LPA gene 60 discontinued Viread 60 Epstein Barr Virus EBV 60 Heterozygous 60 enterococcal 60 ZD# [001] 60 glycopeptide 60 TNF Tumor Necrosis Factor 60 Tyrosine Kinase Inhibitor 60 CYT# potent vascular disrupting 60 CDK inhibitor 60 UGT#A# 60 Endometrial 60 VSV G 60 Hepatitis B Virus 60 bactericidal activity 60 Interferon alfa 60 pharmacokinetic interactions 60 Kinase Inhibitor 60 E. faecalis 60 interferon alfa 2b 60 Inactivated 60 selective agonist 60 BENICAR HCT 60 MnSOD 60 deoxy 60 administered concomitantly 60 Genotypes 60 gastrointestinal stromal tumors GISTs 60 immunized mice 60 Interferon Beta 60 Polymerase 60 trimethoprim 60 Platinol ® cisplatin 60 methicillin resistant MRSA 60 Nucleoside 60 BARACLUDE ® 60 Enterobacteriaceae 60 nelfinavir 59 COL#A# 59 voriconazole 59 nelfinavir Viracept 59 autoantibody levels 59 R#C 59 nucleoside analogues 59 Prolongs Survival 59 G#A [001] 59 constitutively expressed 59 CHO K1 59 EP# [003] 59 PegIFN 59 Alkaline Phosphatase 59 NNRTIs 59 Secretase 59 IgM 59 cytidine 59 cisplatin resistant 59 EGFR mutant 59 homozygote 59 pegylated alpha interferon 59 A#V 59 potent inhibitory 59 hemagglutination inhibition HAI 59 BRAF V#E mutation 59 S aureus 59 protein tyrosine phosphatase 59 Recombinant Human 59 Thiovir 59 S. enterica 59 P#Y# [001] 59 Capecitabine 59 Dasatinib 59 chronic eosinophilic leukemia 59 evaluating tivozanib 59 Trichophyton rubrum 59 X# X# X# 59 dasatinib Sprycel 59 metaplasia 59 CYP#D# gene 59 interferon IFN 59 hMPV 59 ESBL producing 59 thalidomide Thalomid 59 CD3 + 59 null mice 59 androgen independent 59 Anthrax Toxin 59 DLTs 59 wildtype 59 envelope glycoprotein 59 radezolid 59 HDL2 59 Antitumor Activity 59 selectively binds 59 Haemophilus 59 Oral Fingolimod 59 Plasmid DNA 59 Situ Hybridization 59 C#BL/#J 59 BRCA1 BRCA2 59 Novel Inhibitor 59 parainfluenza virus 59 replicase 59 Adrenergic 59 Dendritic Cells 59 binds selectively 59 bevacizumab Avastin R 59 μmol L 59 PON1 gene 59 Lymphocytic 59 succinate dehydrogenase 59 Peginterferon Alfa 2a 59 immunofluorescence staining 59 HLA DR4 immune 59 beta lactams 59 TRAIL R2 59 FTC TDF 59 Emtriva Viread 59 ErbB2 positive 59 Selective Inhibitor 59 cytopathic 59 LRAT 59 Candida glabrata 59 RT PCR assay 59 fluoropyrimidine 59 fluconazole resistant 59 hyperplastic 59 S. pyogenes 59 alpha2 59 HIV coinfected 59 DermaVir 59 HIV RNA 59 BRAF V#E 59 V#E 59 lopinavir 59 PEGylated anti 59 Posaconazole 59 neoplasias 59 ASCUS 59 indinavir Crixivan 59 dihydrofolate reductase 59 cidofovir 59 gastric adenocarcinoma 59 Immunohistochemical analysis 59 interleukin IL -# 59 pramipexole dihydrochloride 59 nanomolar 59 resistant isolates 59 seronegative 59 CTLs 59 Tubulin 59 CD# + [001] 59 epithelial tumors 59 highly immunogenic 59 amino acid substitution 59 Complicated Skin 59 azacytidine 59 uricase 59 TO AVOID PREGNANCY WHILE 59 Janus kinase 59 TIMP 1 59 FOLFOX6 59 bacillary 59 TOP2A 59 HER2 expression 59 PF# [002] 59 RASSF1A 59 NKX#.# 59 Non inferiority 59 Salmonella Shigella 59 xenograft models 59 renal cortical 59 MLH1 59 patients coinfected 59 S. aureus isolates 59 MenACWY 59 anti CD3 59 CD#c 59 MIC# [001] 59 intraperitoneally 59 murine models 59 HLA DR2 59 TMEM#B 59 essential thrombocythemia ET 59 Mg Usa 59 generation antisense inhibitor 59 ritonavir boosted lopinavir 59 IFN γ 59 locoregional recurrence 59 androgen receptor AR 59 β blockers 59 constitutively activated 59 haematopoietic 59 HBeAg positive 59 Bios v 59 HPV subtypes 59 TOP2A gene 59 PTPN# 59 #q# deletion 59 HER2 overexpression 59 myelodysplastic myeloproliferative diseases 59 phosphorothioate 59 oral prodrug 59 ^ sup #m 59 Abacavir 59 SB# chipset 58 immunomodulatory therapy 58 PEG Interferon 58 lamivudine 3TC 58 Cholinesterase Inhibitors 58 urothelial carcinoma 58 variant alleles 58 Hepatitis B HBV 58 ribavirin RBV 58 Tipranavir 58 CYP #D# 58 TVID 58 investigational integrase inhibitor 58 Enterococcus faecalis 58 ribosomal protein 58 piperacillin tazobactam 58 K#M# 58 aspartate aminotransferase 58 methicillin sensitive 58 PCR assay 58 CCR5 antagonist 58 Nilotinib 58 Amino acid 58 Monoclonal Antibody 58 virus AAV 58 genes CYP#C# 58 hypermethylated 58 Immunohistochemical staining 58 LEXIVA r 58 Linezolid 58 Rimantadine 58 posaconazole 58 somatostatin 58 missense mutations 58 subtyped 58 Anti Tumor Activity 58 abnormal cytology 58 Serologic 58 Peg IFN 58 microcephalin 58 synthetic analogues 58 colorectal carcinoma 58 HCV Genotype 58 capsular polysaccharide 58 MYH9 gene 58 G# G# 58 R#W [002] 58 SensoLyte 58 allelic variants 58 ESBLs 58 Bosutinib 58 mRNA encoding 58 Daptomycin 58 metastatic colorectal carcinoma 58 K ras gene 58 APOC3 58 somatostatin analogue 58 tubulin polymerization 58 bicalutamide 58 HLA B# 58 P aeruginosa 58 meropenem 58 epidermidis 58 Adjuvanted 58 antiproliferative activity 58 KIT mutations 58 #.# MHz [002] 58 abacavir sulfate lamivudine 58 varicella zoster virus VZV 58 Peginterferon alfa 2b 58 small lymphocytic lymphoma 58 paricalcitol 58 bronchial hyperresponsiveness 58 non nucleoside 58 kDa protein 58 Poliovirus 58 griseofulvin 58 potently inhibited 58 plasma lipid 58 TMPRSS2 ERG 58 antiandrogens 58 Gastrointest Liver Physiol 58 Inactivation 58 Saquinavir 58 virus HBV 58 dimeric 58 Mucosal 58 pegylated liposomal doxorubicin 58 Clusterin 58 ORFs 58 liver metastasis 58 DFMO 58 GPx 58 HCT# 58 plasma pharmacokinetics 58 human metapneumovirus 58 Amplicor 58 Hsp# Inhibitor 58 heterozygote 58 #mg/#mg 58 protease inhibitor PI 58 fluticasone propionate FP 58 Demonstrates Significant 58 NOD SCID mice 58 doxorubicin cyclophosphamide 58 PD LID 58 chemokine receptor 58 M. pneumoniae 58 Interferon alpha 58 photodiode array 58 lysophosphatidic acid 58 mycophenolate mofetil 58 heterozygous 58 Adefovir 58 thyroglobulin 58 Mycoplasma pneumoniae 58 pyrimethamine 58 Fulvestrant 58 adipogenic 58 Tumor Response 58 F. tularensis 58 Disease Progression 58 VZV 58 cynomolgus monkeys 58 Cathepsin B 58 Peginterferon 58 inherited maternally 58 sequence homology 58 NS#/#A protease 58 LNCaP cells 58 gene amplification 58 lymphocytosis 58 ara C 58 relapsed MM 58 intracranial hemorrhage ICH 58 prostate cancer CaP 58 mutant allele 58 missense 58 pyruvate kinase 58 GSTM1 58 Angiotensin Converting Enzyme 58 Telithromycin 58 Chemokine Receptor 58 nonmetastatic 58 HMG CoA reductase inhibitors 58 E#/E# [001] 58 T2 lesions 58 coexpression 58 siRNA knockdown 58 antiandrogen 58 Polymorphisms 58 SGPT 58 IFN ß 58 Klebsiella pneumoniae 58 Protease 58 HBV genotype 58 Refractory Hodgkin Lymphoma 58 HLA DRB1 * 58 herpesviruses 58 Motherboard Review 58 NEUGENE 58 Cytotoxicity 58 Polymorphism 58 ERBB2 58 antibiotic susceptibility 58 peritoneal carcinomatosis 58 colorectal adenoma 58 polycythemia vera PV 58 ErbB1 58 orthotopic model 58 EGFR TKI 58 ACC2 58 Soft Tissue Sarcoma 58 sulindac 58 bexarotene 58 transgenic mouse models 58 lispro 58 immunocompetent 58 Fluconazole 58 virulence genes 58 Cytochrome P# 58 Novel Oral 58 AST ALT 58 recombinants 58 metastatic neuroendocrine tumors 58 Prognostic significance 58 efavirenz emtricitabine 58 H5 H7 58 dimeglumine 58 PTP1B 58 Lactobacillus casei 58 E# E# [002] 58 rFSH 58 seropositivity 58 Mutational 58 transiently transfected 58 recurrent glioblastoma multiforme 58 thymidylate synthase TS 58 ß blockers 58 liposomal amphotericin B 58 ENPP1 58 dehydroepiandrosterone sulfate 58 C#A [002] 58 Histone 58 monophasic 58 tinidazole 58 Pgp 58 Enterobacter 58 C. albicans 58 Monocytes 58 dermatophytes 58 favorable pharmacokinetic profile 58 grade squamous intraepithelial 58 treat benign prostatic 58 sulfamethoxazole 58 bronchodilatory 58 Proliferative 58 T#A [001] 58 hydroxylase 58 Protelos R 58 biochemical relapse 58 Monotherapy 58 invasive lobular 58 R bisoprolol Euthyrox 58 zoledronate 58 F FLT 58 CD# antibodies 58 prolonged QT interval 58 itraconazole 58 Naive Patients 58 Liposomal 58 intraepithelial neoplasia 58 vincristine doxorubicin 57 heparanase 57 normal karyotype 57 baseline LDH 57 EphB4 57 Autoantibodies 57 nucleotide substitutions 57 Virus Infection 57 #.#-# [029] 57 Western blotting 57 COPEGUS R 57 MSH2 57 IL2 57 dose proportionality 57 IgG4 57 GRASPA ® 57 adenoviral 57 BRAF mutation 57 Teriflunomide 57 Escherichia coli Klebsiella pneumoniae 57 NPM1 57 tetracycline antibiotic 57 Lopinavir 57 TT genotype 57 See CLINICAL PHARMACOLOGY 57 NS5b 57 S/GSK# 57 Prostatic 57 MDA MB 57 recombinant interferon 57 X4 tropic 57 Immune Responses 57 NMDA antagonists 57 E#K [002] 57 SIRT2 57 valine 57 unmutated 57 constitutively active 57 tryptase 57 immunoglobulin G 57 immunohistochemical 57 Levaquin levofloxacin 57 substrates inhibitors 57 log# copies mL 57 transfected cells 57 Protein Kinase C 57 GSTT1 57 VNTR 57 differentially expressed genes 57 pulmonary metastases 57 E. faecium 57 germline mutation 57 immunoconjugate 57 fumarate 57 EGFR mutations 57 Kahalalide F 57 Tumor Necrosis Factor 57 apolipoprotein E4 57 monogenic 57 idarubicin 57 mg kg dose 57 D aspartate 57 HLA DQ2 57 thyrotropin 57 nucleoside analog 57 Salmonella enterica 57 hydrolase 57 ALT normalization 57 follicular lymphomas 57 procainamide 57 guaiac 57 BoNT 57 ribavirin USP 57 SensoLyte ™ 57 rs# [002] 57 Presents Preclinical Data 57 HPV# 57 gastric carcinogenesis 57 Cancer Incidence Mortality 57 TMC# r 57 plus medroxyprogesterone acetate 57 coagulase negative staphylococci 57 thienopyridine 57 ganciclovir 57 Staphylococcus aureus methicillin susceptible 57 K. pneumoniae 57 Xeloda ® 57 Moxifloxacin 57 Pegylated Interferon 57 hepatic lipase 57 advanced adenoma 57 gene loci 57 TTR gene 57 Receptor Antagonists 57 T. vaginalis 57 D# D# D# D# 57 antiapoptotic 57 germline mutations 57 Infectivity 57 MVA BN R 57 papillary RCC 57 etiologic agent 57 histologic subtype 57 interleukin IL 57 Enterococcus faecium 57 G CSFs 57 Myocardial Perfusion Imaging 57 Streptococcus pyogenes 57 Propionibacterium 57 MR Angiography 57 lactis 57 mCi 57 APOE e4 57 macrolide antibiotic 57 imatinib resistance 57 adamantanes 57 bendamustine 57 BALB c 57 HGPIN 57 Diffuse Large B 57 Trypanosoma 57 sitosterol 57 severe neutropenia 57 T# R# 57 serum antibodies 57 Alferon LDO 57 vinca alkaloids 57 preferentially bind 57 Multiplexed 57 stably transfected 57 resectable 57 tyrosine phosphorylation 57 gamma tocotrienol 57 Adenomas 57 nitrofurantoin 57 tipranavir ritonavir 57 Cardiac Troponin 57 Xanafide 57 poor metabolizers 57 LPS induced 57 polyglutamate 57 aT cell 57 Epirubicin 57 MDRSP 57 hematological parameters 57 triglycerides TG 57 upregulates 57 proteasome inhibitor 57 castrate resistant 57 CCR5 tropic 57 cisplatin gemcitabine 57 Humanized Anti 57 isotype 57 S#F [001] 57 quinolone antibiotics 57 Varistors 57 ergot alkaloids 57 APTIMA R 57 PI3 57 Nucleic Acid Test 57 M#T [001] 57 CD8 T cell 57 Salmonella spp 57 Moraxella catarrhalis 57 hormone receptor negative 57 Cytotoxic T 57 endocrine therapies 57 cytokeratin 57 adefovir dipivoxil 57 paclitaxel Taxol 57 peptide antigens 57 rhIL 7 57 GW# [003] 57 Si#DB 57 EMRG VIO 57 gene rearrangements 57 Hycamtin ® 57 ELISPOT assay 57 FK# 57 leflunomide 57 NPH insulin 57 radioligand 57 VP# [004] 57 Tigecycline 57 Agilent #B [002] 57 HMC#LP#E 57 Phospholipase 57 kidney allograft 57 volociximab 57 selective kinase inhibitor 57 homodimers 57 P2X 57 Ribosomal 57 Ribavirin causes 57 S# S# [001] 57 acyltransferase 57 virologic failure 57 nonvaccine 57 refractory chronic lymphocytic 57 FUSILEV enhances 57 beta actin 57 L# L# [003] 57 Asymptomatic 57 glycosylated 57 pegylated interferon alfa 57 HRCT 57 certolizumab 57 DermaVir Patch 57 antiestrogen 57 intravenous dosing 57 asymptomatic metastatic 57 SMN1 57 Babesia 57 SSc 57 cagA 57 completely resected 57 pegylated interferons 57 Submits IND 57 BMPR2 57 irreversible inhibitor 57 Lactobacillus rhamnosus 57 Monoclonal 57 Allogeneic 57 antisense compounds 57 Leukotriene 57 S#P 57 stavudine d4T 57 effector function 57 1GB PC2 57 thrombin receptor 57 MVA BN ® 57 relapsed ALL 57 histone deacetylase inhibitor 57 dual tropic 57 inhibitory concentration 57 Enzastaurin 57 demonstrated antitumor activity 57 chlamydial 57 Fludarabine 57 adenylate cyclase 57 benzimidazole 57 6U cPCI 57 serologic testing 57 BCR ABL1 57 ERCC1 57 serpin 57 potently inhibit 57 gene APOE 57 CD8 + cytotoxic 57 AMACR 57 T1c 57 Reductase 57 chimeric monoclonal antibody 57 γ secretase 57 JAK#/JAK# 57 neuroblastoma tumors 57 Microplate Reader 57 alpha1 57 selective antagonist 57 Raltegravir 57 V#F mutation 57 Chronic HCV 57 pDCs 57 α β 57 genotype 1a 57 Pegylated interferon 57 LymphoStat B belimumab 57 T2DM 57 microsomal 57 lipid particles 57 receptor inhibitor 57 tumorigenicity 57 Cytogenetic 57 immune globulin intravenous 57 imipenem 57 1alpha 57 nucleotide analog 57 transduced 57 oncoproteins 57 EP4 57 ASUS Unveils 57 GABHS 57 kanamycin 57 invasive ductal 57 anti JCV antibodies 56 Atripla combines 56 Transgenic Mice 56 Vidaza ® 56 liver histology 56 Bt toxins 56 aspartate aminotransferase AST 56 Kinase Inhibitors 56 Input Voltage 56 RNA polymerases 56 recurrent genital herpes 56 Study Evaluating 56 Virulence 56 UNI XC 56 Pooled Analysis 56 anastrazole 56 TUNEL 56 immunodominant 56 UD5 56 hemagglutinin gene 56 Chemoradiation 56 TET2 56 antitrypsin 56 chemo immunotherapy